Home > Healthcare > Drug Device Combination > Therapeutic Systems > Cold Pain Therapy Market

Cold Pain Therapy Market Share

Report ID: GMI10118
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Cold Pain Therapy Market Share

The cold pain therapy industry is competitive in nature, with various large multinationals, small and mid-sized companies competing in the industry. The development and launch of novel therapeutics with improved efficiency and cost-effectiveness are key market strategies for cold pain therapeutic product manufacturers, driving competition and innovation in the industry. This emphasis on innovation aims to address evolving clinical needs and enhance patient outcomes, positioning companies to gain market share and meet the growing demand for novel cold pain therapy.

Cold Pain Therapy Market Companies

Some of the eminent market participants operating in the cold pain therapy industry include:

Bird & Cronin, LLC
Breg, Inc.
Cardinal Health
Compass Health Brands
Enovis Corporation
Hisamitsu Pharmaceutical Co., Inc.
Johnson & Johnson Consumer Inc.
Össur
Performance Health
Polar Products Inc.
Rapid Aid
Rohto pharmacautical
Romsons Group of Industries
Sanofi
ThermoTek

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Cold pain therapy industry size was worth USD 1.9 billion in 2023 and will grow at 4.8% CAGR between 2024 and 2032, driven by the rising prevalence of sports injuries and musculoskeletal disorders along with the increasing demand for effective pain management solutions.

The musculoskeletal disorders segment recorded USD 777.4 million in 2023, primarily due to the high prevalence of conditions like arthritis, back pain, and tendonitis and increasing awareness of the benefits in reducing inflammation and accelerating recovery.

North America cold pain therapy industry size was USD 676.2 million in 2023, propelled by the high prevalence of sports injuries and musculoskeletal disorders, advanced healthcare infrastructure, coupled with significant investments in R&D of innovative cold therapy products.

Bird & Cronin, LLC, Breg, Inc., Cardinal Health, Compass Health Brands, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson Consumer Inc., Performance Health, Polar Products Inc., Rapid Aid, Romsons Group of Industries, and Sanofi among others.